Status:
UNKNOWN
Follow-up of SPTS in Patients With Raynaud's Phenomenon
Lead Sponsor:
University Medical Center Groningen
Conditions:
Raynaud Phenomenon
Eligibility:
All Genders
16+ years
Brief Summary
Background: Raynaud's phenomenon is a vasospasm of the extremities, leading to extensive discomfort in daily life and potentially severe ischemia. Some patients are resistant to conventional vasodilat...
Eligibility Criteria
Inclusion
- Raynaud's phenomenon of the hands
- Scheduled SPTS as treatment for RP
- Age ≥ 16 years
Exclusion
- • SPTS for other indications than RP
Key Trial Info
Start Date :
March 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04015193
Start Date
March 28 2019
End Date
March 1 2025
Last Update
July 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Netherlands, 9700 RB